Compare Pfizer Inc (PFE) vs Sirius XM Holdings Inc (SIRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Sirius XM Holdings Inc — how do they compare? Pfizer Inc trades at $28.14 (market cap $158.56B), while Sirius XM Holdings Inc trades at $27.15 (market cap $8.87B). The key difference: Pfizer Inc is far larger — about 17.9× Sirius XM Holdings Inc's market cap, and Pfizer Inc pays the higher dividend (6.18%). Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and Sirius XM Holdings Inc for 102 Days on average.
| PFE | SIRI | |
|---|---|---|
Market Cap | $158.56B | $8.87B |
Volume | 44,138,282 | 4,324,672 |
Sector | Health | Media |
52-Week High | $29.02 | $32.59 |
52-Week Low | $23.67 | $19.92 |
Typical Hold Time | 158 Days | 102 Days |
Enterprise Value | $210.06B | $18.16B |
Dividend Yield | 6.18% | 4.1% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
SIRI trades at $25.95, down 1.56% with a bearish technical signal. The company shows mixed fundamentals with a P/E of 10.57 and P/B of 0.75 indicating potential undervaluation, but recent earnings misses and a significant net loss in 2024 raise concerns. Positive cash flow growth and a 62.5% analyst buy rating provide support, while the YouTube partnership offers growth potential.
The stock presents a value opportunity with upside to the $34.43 consensus target, but faces execution risks from subscription pressure and high debt. Recent institutional buying and management's focus on cash flow growth are positive catalysts, though technical weakness and competitive threats warrant caution for near-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Sirius XM Holdings Inc
SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →
